305 related articles for article (PubMed ID: 27489053)
1. Secondary preventive medication use in a prevalent population-based cohort of acute coronary syndrome survivors.
Gunnell AS; Hung J; Knuiman MW; Nedkoff L; Gillies M; Geelhoed E; Hobbs MS; Katzenellenbogen JM; Rankin JM; Ortiz M; Briffa TG; Sanfilippo FM
Cardiovasc Ther; 2016 Dec; 34(6):423-430. PubMed ID: 27489053
[TBL] [Abstract][Full Text] [Related]
2. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study.
Pereira M; Araújo C; Dias P; Lunet N; Subirana I; Marrugat J; Capewell S; Bennett K; Azevedo A
Eur J Prev Cardiol; 2014 Nov; 21(11):1401-8. PubMed ID: 23787795
[TBL] [Abstract][Full Text] [Related]
3. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
[TBL] [Abstract][Full Text] [Related]
4. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
Lee HY; Cooke CE; Robertson TA
J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
[TBL] [Abstract][Full Text] [Related]
5. Patients with acute coronary syndrome and nonobstructive coronary artery disease in the real world are markedly undertreated.
De Ferrari GM; Leonardi S; Baduena L; Chieffo E; Lesce A; Repetto A; Previtali M
J Cardiovasc Med (Hagerstown); 2011 Oct; 12(10):700-8. PubMed ID: 21738050
[TBL] [Abstract][Full Text] [Related]
6. Chronic polytherapy after myocardial infarction: the trade-off between hospital and community-based providers in determining adherence to medication.
Di Martino M; Alagna M; Lallo A; Gilmore KJ; Francesconi P; Profili F; Scondotto S; Fantaci G; Trifirò G; Isgrò V; Davoli M; Fusco D
BMC Cardiovasc Disord; 2021 Apr; 21(1):180. PubMed ID: 33853534
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
[TBL] [Abstract][Full Text] [Related]
8. Nationwide dispensing of cardioprotective medications during the first year following acute coronary syndrome (ANZACS-QI 56).
Butchard M; Kerr AJ; Grey C; Wu B; Hider P
N Z Med J; 2021 Mar; 134(1531):36-54. PubMed ID: 33767486
[TBL] [Abstract][Full Text] [Related]
9. Use of evidence-based therapy for the secondary prevention of acute coronary syndromes in Malaysian practice.
Kassab YW; Hassan Y; Aziz NA; Akram H; Ismail O
J Eval Clin Pract; 2013 Aug; 19(4):658-63. PubMed ID: 22845427
[TBL] [Abstract][Full Text] [Related]
10. Sustained sex-based treatment differences in acute coronary syndrome care: Insights from the American Heart Association Get With The Guidelines Coronary Artery Disease Registry.
Udell JA; Fonarow GC; Maddox TM; Cannon CP; Frank Peacock W; Laskey WK; Grau-Sepulveda MV; Smith EE; Hernandez AF; Peterson ED; Bhatt DL;
Clin Cardiol; 2018 Jun; 41(6):758-768. PubMed ID: 29521450
[TBL] [Abstract][Full Text] [Related]
11. Sex Disparities in Post-Acute Myocardial Infarction Pharmacologic Treatment Initiation and Adherence: Problem for Young Women.
Smolina K; Ball L; Humphries KH; Khan N; Morgan SG
Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):586-92. PubMed ID: 26462876
[TBL] [Abstract][Full Text] [Related]
12. Adherence to recommendations for secondary prevention medications after myocardial infarction in Estonia: comparison of real-world data from 2004 to 2005 and 2017 to 2018.
Lõiveke P; Marandi T; Ainla T; Fischer K; Eha J
BMC Cardiovasc Disord; 2021 Oct; 21(1):505. PubMed ID: 34670499
[TBL] [Abstract][Full Text] [Related]
13. In-hospital prescriptions of secondary-prevention medications for post-acute coronary syndrome patients in South Korea
.
Kang HB; Choi M; Yoon SG; Cho YS; Je NK
Int J Clin Pharmacol Ther; 2018 Jan; 56(1):1-11. PubMed ID: 29168689
[TBL] [Abstract][Full Text] [Related]
14. Optimizing prevention and guideline-concordant care in Montenegro.
Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
[TBL] [Abstract][Full Text] [Related]
15. Evidence-based prescribing of drugs for secondary prevention of acute coronary syndrome in Aboriginal and non-Aboriginal patients admitted to Western Australian hospitals.
Gausia K; Katzenellenbogen JM; Sanfilippo FM; Knuiman MW; Thompson PL; Hobbs MS; Thompson SC
Intern Med J; 2014 Apr; 44(4):353-61. PubMed ID: 24528930
[TBL] [Abstract][Full Text] [Related]
16. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109
[TBL] [Abstract][Full Text] [Related]
17. Trends in Gender Differences in Cardiac Care and Outcome After Acute Myocardial Infarction in Western Sweden: A Report From the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART).
Redfors B; Angerås O; Råmunddal T; Petursson P; Haraldsson I; Dworeck C; Odenstedt J; Ioaness D; Ravn-Fischer A; Wellin P; Sjöland H; Tokgozoglu L; Tygesen H; Frick E; Roupe R; Albertsson P; Omerovic E
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175358
[TBL] [Abstract][Full Text] [Related]
18. Variation in critical care unit admission rates and outcomes for patients with acute coronary syndromes or heart failure among high- and low-volume cardiac hospitals.
van Diepen S; Bakal JA; Lin M; Kaul P; McAlister FA; Ezekowitz JA
J Am Heart Assoc; 2015 Feb; 4(3):e001708. PubMed ID: 25725089
[TBL] [Abstract][Full Text] [Related]
19. Statin Utilization Patterns and Outcomes for Patients with Acute Coronary Syndrome During and Following Inpatient Admissions.
Boklage SH; Malangone-Monaco E; Lopez-Gonzalez L; Ding Y; Henriques C; Elassal J
Cardiovasc Drugs Ther; 2018 Jun; 32(3):273-280. PubMed ID: 29855748
[TBL] [Abstract][Full Text] [Related]
20. Sex Differences in In-Hospital Management and Outcomes of Patients With Acute Coronary Syndrome.
Hao Y; Liu J; Liu J; Yang N; Smith SC; Huo Y; Fonarow GC; Ge J; Taubert KA; Morgan L; Zhou M; Xing Y; Ma CS; Han Y; Zhao D
Circulation; 2019 Apr; 139(15):1776-1785. PubMed ID: 30667281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
